Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2012
12/27/2012CA2839711A1 Compositions and methods for inhibition of expression of apolipoprotein c-iii (apoc3) genes
12/27/2012CA2839703A1 Trpm8 antagonists and their use in treatments
12/27/2012CA2839699A1 Trpm8 antagonists and their use in treatments
12/27/2012CA2839621A1 Polymorphs of (s)-pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol-2-yl}-amide
12/27/2012CA2839613A1 Pesticidal compositions and processes related thereto
12/27/2012CA2839573A1 Angiopoietin-like 3 (angptl3) irna compositions and methods of use thereof
12/27/2012CA2839549A1 Modulation of tissue transglutaminase activation in disease
12/27/2012CA2839507A1 Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators
12/27/2012CA2839491A1 Anti-parasitic composition comprising a macrocyclic lactone and levamisole and method of treatment of parasitic infestation
12/27/2012CA2839343A1 Biocompatible film with variable cross-sectional properties
12/27/2012CA2838947A1 Deuterium-enriched 4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-[(4-trifluoro-methyl)phenyl]-1,2-dihydroquinoline-3-carboxamide
12/27/2012CA2838916A1 Metalloenzyme inhibitor compounds
12/27/2012CA2838912A1 Metalloenzyme inhibitor compounds
12/27/2012CA2838909A1 Metalloenzyme inhibitor compounds
12/27/2012CA2838055A1 Method of administration of 4-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia
12/27/2012CA2838039A1 Liquid pharmaceutical composition comprising nitisinone
12/27/2012CA2837820A1 Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
12/27/2012CA2837784A1 Method for manufacturing hydroxyethyl starch derivatives
12/27/2012CA2837727A1 Substituted imidazopyridinyl-aminopyridine compounds
12/27/2012CA2837695A1 Reduced coenzyme q10 crystal having excellent stability
12/27/2012CA2837658A1 Pcsk9-binding polypeptides and methods of use
12/27/2012CA2837429A1 Pharmaceutical composition comprising a trpa1 antagonist and a beta-2 agonist
12/27/2012CA2837178A1 Trpv1 antagonists including dihydroxy substituent and uses thereof
12/27/2012CA2836497A1 Fast dissolving azaperone granulate formulation
12/27/2012CA2836442A1 Dialysis precursor composition
12/27/2012CA2836371A1 Dialysis precursor composition
12/27/2012CA2833775A1 Proteasome inhibitors and processes for their preparation, purification and use
12/26/2012EP2537934A2 Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
12/26/2012EP2537866A1 Hydroxyethyl starch derivatives, method for manufacturing the same and therapeutical uses thereof
12/26/2012EP2537855A1 Analogues of NADP+ or NADPH for use as inhibitors of NADP+ or NADPH-dependent enzymes
12/26/2012EP2537850A1 Organic compounds
12/26/2012EP2537849A2 Azaindoles useful as inhibitors of janus kinases
12/26/2012EP2537847A1 Polymorphs of dasatinib and process for preparation thereof
12/26/2012EP2537845A1 6H-dibenzo[B,E]oxepine derived nonsteroidal mineralocorticoid receptor antagonists
12/26/2012EP2537844A1 Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
12/26/2012EP2537843A2 Preparation of maleate salt of neratininb and its use
12/26/2012EP2537842A1 Crystals of (S)-N-[2-(2,6,7,8-Tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethyl]propionamide
12/26/2012EP2537831A1 Imidazole derivative
12/26/2012EP2537830A1 Compounds and compositions as protein kinase inhibitors
12/26/2012EP2537827A1 Process for preparing 4-amino-5-hexenoic acid from succinimide
12/26/2012EP2537534A1 Prodrugs of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their use in transdermal therapeutic systems
12/26/2012EP2537531A2 Composition for percutaneous administration of tolterodine with reduced skin irritation
12/26/2012EP2537526A1 Method and compound for the treatment of valvular stenosis
12/26/2012EP2537524A2 Treatment of T-cell mediated diseases
12/26/2012EP2537521A1 Unit dosage for brain health
12/26/2012EP2537520A1 Hepatics C therapies
12/26/2012EP2537519A1 Neuropathic pain alleviating agent
12/26/2012EP2537518A1 Fast dissolving azaperone granulate formulation
12/26/2012EP2537517A1 Deuterium-enriched 4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-[(4-trifluoro-methyl)phenyl]-1,2-dihydroquinoline-3-carboxamide
12/26/2012EP2537516A2 Composition for percutaneous administration of tolterodine with improved skin permeation
12/26/2012EP2537515A1 Dietetic product for treating mitochondrial dysfunctions
12/26/2012EP2537514A1 Antimicrobial preparations having a content of octenidine dihydrochloride encapsulated in liposomes
12/26/2012EP2537422A1 Lifespan extending agent
12/26/2012EP2536748A1 Neuregulin antagonists and use thereof in treating cancer
12/26/2012EP2536737A1 A method for preparation of the tetrasaccharide lacto-n-neotetraose (lnnt) containing n-acetyllactosamine
12/26/2012EP2536736A1 Production of 6'-o-sialyllactose and intermediates
12/26/2012EP2536734A1 Forms of rifaximin and uses thereof
12/26/2012EP2536733A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
12/26/2012EP2536732A2 Cyclic tetrapeptides and therapeutic applications thereof
12/26/2012EP2536731A1 Substituted spiroindolinones
12/26/2012EP2536730A1 Pyrrolopyrimidine compounds as inhibitors of cdk4/6
12/26/2012EP2536729A1 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
12/26/2012EP2536728A1 Pyrazole derivatives as jak inhibitors
12/26/2012EP2536727A1 Deuterated pyrrolopyrimidine compounds as inhibitors of cdk4/6
12/26/2012EP2536726A1 Diaryl ether linked pyrrolo [2,1-c][1,4]benzodiazepine hybrids and process for the preparation thereof
12/26/2012EP2536723A1 Pyrazolo piperidine derivatives as nadph oxidase inhibitors
12/26/2012EP2536722A1 Bicyclic compounds and their uses as dual c-src / jak inhibitors
12/26/2012EP2536721A1 Pyrazolo piperidine derivatives as nadph oxidase inhibitors
12/26/2012EP2536720A1 Triazolo [4, 5 - b]pyridin derivatives
12/26/2012EP2536719A1 Heterocyclic compounds and uses as anticancer agents
12/26/2012EP2536718A1 Heterocycles as potassium channel modulators
12/26/2012EP2536717A1 Aminothiazolones as estrogen related receptor-alpha modulators
12/26/2012EP2536716A1 Aminothiazolones as estrogen related receptor-alpha modulators
12/26/2012EP2536714A2 A novel 5-membered heterocycle derivatives and manufacturing process thereof
12/26/2012EP2536713A1 (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors
12/26/2012EP2536711A1 5-ht receptor modulators
12/26/2012EP2536710A2 Piperidine derivatives
12/26/2012EP2536709A2 Prolylhydroxylase inhibitors and methods of use
12/26/2012EP2536708A2 Androgen receptor modulators and uses thereof
12/26/2012EP2536707A1 Process for the preparation of alpha form of imatinib mesylate
12/26/2012EP2536706A1 Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
12/26/2012EP2536705A1 Polymorphic forms of lubiprostone
12/26/2012EP2536704A1 Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase
12/26/2012EP2536702A1 New crystalline form of a cyclopropyl benzamide derivative
12/26/2012EP2536701A1 Solid forms comprising a cyclopropyl amide derivative
12/26/2012EP2536699A2 Substantially pure salts of febuxostat and processes for preparation thereof
12/26/2012EP2536697A2 Novel antifungal triazole derivatives
12/26/2012EP2536696A1 Pyrimidine derivatives
12/26/2012EP2536695A1 Improved processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine
12/26/2012EP2536694A1 Glycine sulfonamides for use as inhibitors of diacylglycerol lipase
12/26/2012EP2536693A1 Substituted 2-imidazolidones and analogs
12/26/2012EP2536690A1 Multifunctional radical quenchers and their use
12/26/2012EP2536689A1 Aryl carboxamide derivatives as sodium channel inhibitors for treatment of pain
12/26/2012EP2536686A1 Cyclic keto-enols for therapy
12/26/2012EP2536433A2 Epithelial membrane protein 2 (emp2) binding reagents and their therapeutic uses in ocular diseases
12/26/2012EP2536431A2 Compositions and methods for inhibiting mmset
12/26/2012EP2536414A1 Method for preventing cancer metastasis
12/26/2012EP2536413A1 Use of synthetic polysulphated oligosaccharides as cleaning agents for a wound
12/26/2012EP2536412A2 An inhalable pharmaceutical composition
12/26/2012EP2536411A2 Inhibitors of long and very long chain fatty acid metabolism as broad spectrum anti-virals
1 ... 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 ... 7860